Single-Use Bioprocess Platform for Veterinary Vaccine and Biopharmaceutical Pilot-Scale Production
11th June 2020 | 10:00 am CET | Francis Verhoeye, Global Pilot Operations Leader at Zoetis Inc. |BOOK FREE SEAT FOR THIS WEBINAR
- Understand the implementation journey taken to accelerate veterinary biological product development
- Identify the challenges of integrating vaccine and biopharmaceutical processes
- Learn about the single use qualification and implementation process in a multi-product facility
Presented by Francis Verhoeye, Global Pilot Operations Leader at Zoetis Inc.
Francis Verhoeye serves as Global Pilot Operations Lead at Zoetis and is managing at the international level the Pilot Network specialized in the development, scale-up and transfer of vaccines and biological products using disposable technologies. Francis started his professional career in the field of pharmacology and bioengineering at the University of Louvain in Belgium. He benefits from more than 17 years operational experience in the field of animal and human cell culture techniques, upstream development and scale up as well as technology transfer management and disposable solutions implementation (through management positions held at Novasep, LFB Biotechnologies, Cardio3 Biosciences and GSK). Francis holds a PhD in Biology and a complementary degree in Management from the University of Louvain, Belgium.
Sponsored by Thermo Fisher Scientific
Thermo Fisher Scientific supports developers and manufacturers of biological-based therapeutics and vaccines with a world-class product portfolio that spans the bioprocessing workflow from discovery through large-scale commercial production. Starting with production-grade raw materials and supply chain logistics, we provide solutions and services across the manufacturing value stream and through QC release of finished goods, including upstream cell culture, downstream purification, analytical and QC testing, end-to-end single-use technologies, and comprehensive measurement and control solutions.